Marie Skłodowska-Curie Postdoctoral Fellowships, DKFZ (German Cancer Research Center), Germany

Marie Skłodowska-Curie Actions (MSCA) Individual Fellowships 2019

Marie Skłodowska-Curie Postdoctoral Fellowships: The European Commission offers Marie Skłodowska-Curie Postdoctoral Fellowships for up to 24 months, providing living and mobility allowances, family support, research budgets, and access to a global network. Eligible candidates must hold a PhD, have up to 8 years of postdoctoral experience, and not have resided or worked in Germany for more than 12 months prior to September 11, 2024.

Designation: Marie Skłodowska-Curie Postdoctoral Fellow

Research Area: Multidisciplinary

Location: DKFZ (German Cancer Research Center), Germany


  • Hold a PhD degree, defended before September 11, 2024
  • Maximum 8 years of postdoctoral research experience by September 11, 2024
  • Not have resided or worked in Germany for more than 12 months in the 36 months immediately before September 11, 2024

Job Description:

  • Conduct independent research projects supported by the Marie Skłodowska-Curie Fellowship
  • Collaborate with DKFZ Principal Investigators on research proposals and projects
  • Attend Marie Curie MasterClasses and receive personalized feedback from grants experts
  • Submit application materials by May 13, 2024, including CV, motivation letter, and choice of Principal Investigators
  • Shortlisted candidates will collaborate with Principal Investigators to develop proposals for the fellowship

How to Apply:

  • Send application via by May 13, 2024, including:
    • Form: “Registration as pre-candidate for Marie Skłodowska-Curie Postdoctoral Fellowships (MSC-PF, Call 2024)”
    • CV with list of publications (max. 3 pages)
    • Motivation letter (max. 1 page) detailing research interests and career plans
  • Choose up to three DKFZ Principal Investigators from the provided list
  • Selected candidates will join online seminars (MasterClasses) on June 26, July 3, and July 10, 2024
  • Submission deadline for MSC-PF proposal to the European Union is September 11, 2024

Last Date for Apply: May 13, 2024

For inquiries, contact

Note: Submission of a proposal and participation in support activities do not guarantee a postdoctoral position at DKFZ. Employment contract is contingent upon award of the Marie Curie Postdoctoral Fellowship by the European Commission.


  • Prof. Dr. Christof Niehrs (Cell Biology and Tumor Biology)
    • Developing ROTACs for Targeted Cancer Therapy 🎯
    • Targeting casein kinase 1 – DDX3 signaling for cancer drug development 🔬
  • Prof. Dr. Tobias Dick (Redox Regulation)
    • Investigating ferroptosis resistance in tumor cells 🧬
    • Exploring sulfur metabolism’s role in cytoprotection ⚗️
    • Developing tools for studying redox metabolism 🛠️
  • Dr. Wilhelm Palm (Cell Signaling and Metabolism)
    • Dissecting cancer metabolism through CRISPR screens 🧬
    • Understanding oncogenic signaling’s regulation of mitochondrial metabolism 🧪
    • Characterizing mammalian genes of unknown function 🧬
  • Prof. Dr. Michaela Frye (Mechanisms Regulating Gene Expression)
    • Researching RNA modifications in cancer and immune cells 🧬
    • Focusing on early detection and prevention of cancers 🚨
  • Prof. Dr. Karsten Rippe (Functional and Structural Genomics)
    • Analyzing therapy resistance mechanisms through single-cell multi-omics 🧬
    • Investigating phase separation in chromatin states 🧬
    • Studying intra-tumor heterogeneity through spatially resolved omics 🌐
  • PD Dr. Maïwen Caudron-Herger (RNA-Protein Complexes & Cell Proliferation)
    • Studying riboregulation in mitosis 🧬
    • Investigating the impact of RNA on mitotic protein regulation 🧬
  • Prof. Dr. Rocio Sotillo (Molecular Thoracic Oncology)
    • Utilizing in vivo CRISPR screens for lung cancer research 🧬
    • Exploring tumor suppressors and resistance mechanisms 🛡️
  • Prof. Dr. Jeroen Krijgsveld (Proteomics of Stem Cells and Cancer)
    • Maintaining proteostasis and single-cell proteomics 🧬
    • Analyzing proteome networks using mass spectrometry 🌐
  • Prof. Dr. Benedikt Brors (Applied Bioinformatics)
    • Applying machine learning to understand tumor-immune microenvironment in pancreatic cancer 🧬
    • Utilizing multiomics data analysis for predictive modeling 📊
  • Prof. Dr. Stefan Fröhling (Translational Medical Oncology)
    • Focusing on molecularly guided cancer therapies 🎯
    • Investigating precision oncology and molecular pathogenesis of rare cancers 🧬
  • Dr. Christiane Opitz (Metabolic Crosstalk in Cancer)
    • Studying metabolic regulation at the interface of cancer and the immune system 🧬
  • Dr. Ana Banito (Soft-Tissue Sarcoma)
    • Researching cell of origin for pediatric sarcomas 🧬
    • Investigating tumor maintenance and immune escape mechanisms 🛡️
  • Dr. Aurélie Ernst (Genome Instability in Tumors)
    • Deciphering chromothripsis’s mechanistic basis in cancer 🧬
    • Studying its occurrence and translational implications 🌐
  • Dr. Lena Kutscher (Neurodevelopmental principles underlying pediatric brain cancer)
    • Investigating neurodevelopmental principles in pediatric brain cancer 🧬
  • Dr. Federico Canzian (Genomic Epidemiology)
    • Studying genetic epidemiology of cancer susceptibility and prognosis 🧬
  • Dr. Mahdi Fallah, MD, PhD (Preventive Oncology)
    • Researching risk-adapted cancer screening and prevention strategies 🚨
  • PD. Dr. med. Titus Brinker (Digital Biomarkers for Oncology)
    • Developing explainable AI in image classification for oncology 🤖
    • Utilizing deep learning strategies for high-throughput proteomics 🧬
  • Prof. Dr. med. Michael Platten (Neuroimmunology and Brain Tumor Immunology)
    • Utilizing immune repertoires and AI for personalized cell therapies in cancer 🧬
    • Rapid, high-throughput manufacture of DANN delivery vectors 🧬
  • Dr. Felix J. Hartmann (Systems Immunology and Single-Cell Biology)
    • Quantifying immune function and cellular metabolism in human cancer spatially 🌐
  • Prof. Dr. Dr. Henri-Jacques Delecluse (Pathogenesis of Virus Associated Tumors)
    • Investigating genetics and structural biology of Epstein-Barr virus 🦠
  • Dr. Marco Binder (Dynamics of early viral infection and the innate antiviral response)
    • Elucidating the interplay between endogenous viruses and the immune system in cancer development 🦠
  • Prof. Dr. Oliver Jäkel (Medical Physics in Radiation Oncology)
    • Relating MRI to morphological biomarkers for prognostic response assessment during radiotherapy 🧬
  • Prof. Dr. Leif Schröder (Translational Molecular Imaging)
    • Using MRI and NMR spectroscopy with hyperpolarized contrast agents for molecular imaging 🧬


Please enter your comment!
Please enter your name here